AUREUM DIAGNOSTICS LIMITED

AUREUM DIAGNOSTICS LIMITED is an active private limited company (company number 13201459) incorporated on 15 February 2021, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 March 2026, showing net assets of £987k and cash of £396k, with 11 employees on average. Net assets rose 237% on the prior period (£293k). Across the last 3 periods on record the net-asset trend is volatile.

No active person with significant control is registered.

• persons with significant control statement · since 1 March 2025
• PE
  Miss Patricia Elaine Reynolds

  Individual · since 15 February 2021 · ceased 8 October 2021

  • owns 75–100% of shares
  • holds 75–100% of voting rights
  • can appoint or remove directors
  75–100%
• University Of Strathclyde

  corporate entity, Scotland · since 8 October 2021 · ceased 14 October 2021

  • holds 50–75% of voting rights
  • can appoint or remove directors
  50–75%
• DK
  Dr Damion Kevin Corrigan

  Individual · since 8 October 2021 · ceased 14 February 2024

  • owns 50–75% of shares
  50–75%
• Norcliffe Capital Limited

  corporate entity, England · since 10 October 2021 · ceased 10 February 2025

  • can appoint or remove directors
  • has significant influence or control

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

• Net assets above zeroNet assets £987,316 at 31 March 2026
• Net assets up 10% or more on the prior period+236.9% vs prior period
• Cash at bank of £50,000 or moreCash £396,204
• Three or more accounting periods on record3 periods on record
• Incorporated five or more years agoIncorporated 15 February 2021

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

1. 31 Dec 2027Next accounts duein 434 days
2. 01 Mar 2027Confirmation statement duein 129 days
3. 31 Mar 2026Accounts period endNet assets £987k · small accounts
4. 31 Mar 2025Accounts period endNet assets £293k · small accounts
5. 31 Mar 2024Accounts period endNet assets £792k · small accounts
6. 15 Feb 2021Incorporated

• ELEVEN THERAPEUTICS (UK) LTDLondon · inc. Feb 2021
• NINEVAH THERAPEUTICS LTDLondon · inc. Feb 2021
• CHEM-IQ LTDLondon · inc. Feb 2021
• BIOIMPLANT LTDLondon · inc. Feb 2021
• ACESIS BIOMED LTDLondon · inc. Feb 2021
• COSYNE THERAPEUTICS LIMITEDLondon · inc. Feb 2021

All companies incorporated on 15 February 2021 · in Feb 2021.

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.